Nancy J. Hutson - Oct 3, 2023 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
Director
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
CLSD
Transactions as of
Oct 3, 2023
Transactions value $
$8,600
Form type
4
Date filed
10/4/2023, 05:06 PM
Previous filing
Jun 23, 2023
Next filing
May 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLSD Common Stock Purchase $8.6K +10K +12.05% $0.86 93K Oct 3, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.